found that FMT therapy could effectively improve the Eczema Area and Severity Index (EASI) scores of patients with AD by regulating the Th2/Th17 ratio, serum TNF-α, and total IgE levels, with good safety, and may serve as a new therapeutic approach for inflammatory diseases (146). This evidence concerns the gene IGHE and Alzheimer disease.